Meeta Cardon, MD

Financial relationships

  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    Sarepta
    Topic: 
    Duchene Muscular Dystrophy Gene replacement therapy development
    Date added: 
    12/21/2022
    Relationship end date: 
    05/31/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    LifeSciences Consulting
    Topic: 
    Logistics of administering DMD gene therapy in a clinic setting
    Date added: 
    12/21/2022
    Relationship end date: 
    11/30/2022
Return to 45th Annual Carrell Krusen Neuromuscular Symposium (RP2302A)